maklogo
Market Research Report

Global Biopharma Cold Chain Packaging Market Insights, Size, and Forecast By End User (Pharmaceutical Companies, Biotechnology Companies, Logistics Providers, Healthcare Institutions), By Material Type (Plastic, Glass, Metal, Composites), By Packaging Type (Insulated Containers, Temperature-Controlled Shippers, Cryogenic Packaging, Phase Change Material Packaging), By Application (Vaccines, Biologics, Pharmaceuticals, Cellular Therapies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:49792
Published Date:Jan 2026
No. of Pages:221
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Biopharma Cold Chain Packaging Market is projected to grow from USD 28.5 Billion in 2025 to USD 74.3 Billion by 2035, reflecting a compound annual growth rate of 8.7% from 2026 through 2035. This market encompasses specialized packaging solutions designed to maintain specific temperature ranges for temperature-sensitive biopharmaceutical products throughout the entire supply chain, from manufacturing to patient delivery. It includes passive and active thermal shippers, insulated containers, and temperature monitoring devices. Key market drivers include the escalating demand for biologics, vaccines, and cell and gene therapies, which are highly susceptible to temperature excursions. The increasing prevalence of chronic diseases globally fuels research and development in these sensitive therapeutic areas, necessitating robust cold chain logistics. Furthermore, stringent regulatory requirements from bodies like the FDA and EMA for maintaining product integrity and efficacy are propelling the adoption of advanced cold chain packaging solutions. The rising trend of personalized medicine and home healthcare also contributes to the market's expansion, requiring smaller, more flexible cold chain solutions for last-mile delivery.

Global Biopharma Cold Chain Packaging Market Value (USD Billion) Analysis, 2025-2035

maklogo
8.7%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

A significant trend shaping the market is the growing emphasis on sustainable packaging solutions. Biopharma companies are increasingly seeking eco-friendly materials and reusable packaging options to reduce their environmental footprint. The integration of advanced tracking and monitoring technologies, such as IoT sensors and real-time data loggers, is another crucial trend, enhancing visibility and control over product temperatures during transit. This digital transformation improves supply chain efficiency and enables proactive intervention in case of deviations. Conversely, market restraints include the high initial investment costs associated with advanced cold chain packaging and monitoring systems. The complexity of managing a diverse range of temperature requirements for various biopharmaceutical products also poses a challenge. Additionally, the risk of human error during packaging and handling, despite technological advancements, remains a concern, necessitating continuous training and robust protocols. Market opportunities abound in the development of next-generation smart packaging solutions that offer enhanced insulation, extended temperature maintenance capabilities, and seamless integration with digital platforms for predictive analytics and risk management.

The market is segmented by Packaging Type, Application, End User, and Material Type, with Pharmaceuticals emerging as the leading application segment due to the vast volume and diversity of temperature-sensitive drugs. North America holds the dominant share in the market, primarily driven by a robust biopharmaceutical industry, significant R&D investments, well-established cold chain infrastructure, and stringent regulatory frameworks. The region also benefits from a high concentration of key market players and early adoption of advanced packaging technologies. Asia Pacific is identified as the fastest-growing region, propelled by the rapid expansion of its pharmaceutical and biotechnology sectors, increasing healthcare expenditure, and a growing patient pool. The rising outsourcing of pharmaceutical manufacturing to countries within this region further fuels the demand for sophisticated cold chain packaging. Key players such as American Biopharma, Sofrigam, Cold Chain Technologies, MilliporeSigma, Temptime Corporation, VWR, Pelican BioThermal, Weiss Umweltstechnik, AptarGroup, and Brambles Limited are strategically focusing on product innovation, geographic expansion, and partnerships to capitalize on emerging opportunities and consolidate their market positions. These companies are investing in R&D to develop more efficient, sustainable, and intelligent packaging solutions to meet the evolving demands of the global biopharma industry.

Quick Stats

  • Market Size (2025):

    USD 28.5 Billion

  • Projected Market Size (2035):

    USD 74.3 Billion

  • Leading Segment:

    Pharmaceuticals (42.8% Share)

  • Dominant Region (2025):

    North America (38.2% Share)

  • CAGR (2026-2035):

    8.7%

What is Biopharma Cold Chain Packaging?

Biopharma cold chain packaging ensures temperature integrity of sensitive biological and pharmaceutical products during transport. It involves specialized containers, insulation, and refrigerants like gel packs or dry ice to maintain specific temperature ranges, typically 2 8°C or frozen. This packaging protects vaccines, biologics, and cell therapies from degradation caused by temperature excursions. Its core concept is maintaining a continuous controlled temperature environment from manufacturing to patient. Significance lies in preserving product efficacy, safety, and regulatory compliance, preventing spoilage, and enabling global distribution of life saving medicines. Applications span clinical trials, commercial distribution, and last mile delivery.

What are the Trends in Global Biopharma Cold Chain Packaging Market

  • Smart Packaging Innovations for Enhanced Visibility

  • Sustainable Solutions Driving Eco Conscious Choices

  • Advanced Materials for Extreme Temperature Control

  • Serialization and Traceability Beyond Compliance

Smart Packaging Innovations for Enhanced Visibility

Smart packaging innovations revolutionize biopharma cold chain by integrating sensors and indicators. These technologies provide real time temperature monitoring and tamper evidence, significantly enhancing visibility into product integrity throughout the supply chain. This ensures compliance, reduces waste, and improves overall safety and efficacy of temperature sensitive pharmaceuticals from manufacturer to patient.

Sustainable Solutions Driving Eco Conscious Choices

Biopharma cold chain packaging sees a surge in sustainable solutions. Companies prioritize eco conscious choices, adopting recyclable, reusable, and biodegradable materials to minimize environmental impact. This trend, driven by consumer demand and regulatory pressures, emphasizes innovative designs that ensure product integrity while reducing carbon footprints and waste, reflecting a global commitment to greener supply chains and responsible manufacturing practices across the industry.

Advanced Materials for Extreme Temperature Control

Biopharma packaging increasingly integrates advanced materials for extreme temperature control. Innovative composites and phase change materials are crucial for maintaining precise temperatures during transit of sensitive biologics and vaccines. This trend ensures product integrity across diverse global cold chain conditions, protecting pharmaceutical efficacy and patient safety from severe thermal fluctuations. It minimizes risks of product degradation due to temperature excursions, enhancing reliability.

Serialization and Traceability Beyond Compliance

Biopharma increasingly leverages serialization and traceability for enhanced supply chain visibility, extending beyond regulatory mandates. This proactive approach optimizes inventory, monitors product integrity across the cold chain, and facilitates faster recalls. It improves operational efficiency, builds trust with partners, and elevates patient safety through granular product tracking from manufacturing to administration.

What are the Key Drivers Shaping the Global Biopharma Cold Chain Packaging Market

  • Rising Biologics and Temperature-Sensitive Drug Pipelines

  • Stringent Global Regulatory Compliance for Cold Chain Integrity

  • Technological Advancements in Packaging Materials and Monitoring

  • Expansion of Pharmaceutical Logistics Networks and Global Trade

Rising Biologics and Temperature-Sensitive Drug Pipelines

The increasing development of complex biologic drugs and gene therapies necessitates precise temperature control. These innovative, often injectable medicines are highly sensitive to temperature fluctuations, driving demand for advanced cold chain packaging solutions. Maintaining strict temperature ranges is crucial for their stability, efficacy, and safety during transit and storage. This surge in temperature-sensitive pipelines is a key market accelerator.

Stringent Global Regulatory Compliance for Cold Chain Integrity

Biopharma products, especially biologics, require strict temperature control. Global regulatory bodies like the FDA and EMA mandate meticulous cold chain packaging to ensure product safety, efficacy, and patient well-being. Non-compliance results in severe penalties, product recalls, and reputational damage. This imperative drives demand for advanced packaging solutions that maintain precise temperatures throughout distribution, safeguarding product integrity and fulfilling regulatory requirements across international borders.

Technological Advancements in Packaging Materials and Monitoring

Innovations in packaging materials and monitoring systems are revolutionizing biopharma cold chains. Advanced insulation, phase change materials, and smart sensors ensure precise temperature control and real time tracking. These advancements minimize product degradation, reduce waste, and enhance the safety and efficacy of temperature sensitive biologics globally.

Expansion of Pharmaceutical Logistics Networks and Global Trade

Growth in pharmaceutical logistics networks and international trade is a key driver. As biopharmaceuticals become globally distributed, the need for specialized cold chain packaging intensifies. This expansion requires robust packaging solutions to maintain product integrity across vast supply chains and diverse climatic conditions, ensuring safe and effective delivery worldwide.

Global Biopharma Cold Chain Packaging Market Restraints

Lack of Standardized Regulations and Interoperability Across Regions

Diverse national regulations and varying industry standards impede seamless global operations. This lack of uniformity in cold chain packaging requirements across regions creates significant challenges for biopharma companies. It necessitates tailored solutions for each market, increasing complexity, costs, and the risk of non compliance. Consequently, it hampers the widespread adoption of standardized packaging solutions and limits cross border interoperability, slowing market growth.

High Initial Investment and Operational Costs of Advanced Cold Chain Packaging

Adoption of advanced cold chain packaging in biopharma faces a significant hurdle due to its substantial upfront capital outlay. These sophisticated solutions demand significant investment for procurement and implementation. Furthermore, the ongoing operational expenditures associated with maintaining temperature integrity and specialized logistics contribute to higher overall costs, challenging widespread adoption despite their benefits.

Global Biopharma Cold Chain Packaging Market Opportunities

Expanding Specialized Packaging for Ultra-Cold Cell & Gene Therapy Logistics

The rapid growth of cell and gene therapies creates a critical demand for specialized ultra-cold packaging. This opportunity lies in developing and supplying advanced cryogenic containers, insulated shippers, and integrated monitoring solutions crucial for maintaining product integrity during global logistics. As these life saving therapies become more prevalent, particularly in expanding regions, robust and innovative packaging ensures safe transport from lab to patient. Companies can capitalize by providing tailored, high performance solutions addressing stringent temperature requirements and securing invaluable biologicals throughout the cold chain.

Sustainable & Smart Packaging Solutions for Resilient Biopharma Cold Chains

Developing innovative sustainable packaging, featuring recyclable or reusable materials, coupled with smart sensors for real time temperature monitoring and integrity verification, presents a significant opportunity. These solutions enhance biopharma cold chain resilience, preventing costly product excursions and ensuring drug efficacy from manufacturing to patient. Addressing these critical needs, particularly in high growth regions, optimizes global supply chains, reduces environmental impact, and upholds patient safety by guaranteeing the integrity of vital biopharmaceuticals throughout their journey.

Global Biopharma Cold Chain Packaging Market Segmentation Analysis

Key Market Segments

By Packaging Type

  • •Insulated Containers
  • •Temperature-Controlled Shippers
  • •Cryogenic Packaging
  • •Phase Change Material Packaging

By Application

  • •Vaccines
  • •Biologics
  • •Pharmaceuticals
  • •Cellular Therapies

By End User

  • •Pharmaceutical Companies
  • •Biotechnology Companies
  • •Logistics Providers
  • •Healthcare Institutions

By Material Type

  • •Plastic
  • •Glass
  • •Metal
  • •Composites

Segment Share By Packaging Type

Share, By Packaging Type, 2025 (%)

  • Insulated Containers
  • Temperature-Controlled Shippers
  • Cryogenic Packaging
  • Phase Change Material Packaging
maklogo
$28.5BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why is Pharmaceuticals dominating the Global Biopharma Cold Chain Packaging Market by application?

Pharmaceuticals lead the market with a significant share due to the vast volume and diversity of temperature-sensitive drugs requiring strict cold chain integrity. This segment encompasses a wide range of medications from small molecule drugs to complex biologics, many of which are high-value and critical for patient care, necessitating robust and reliable packaging solutions to prevent degradation and maintain efficacy during transit and storage across global supply chains.

How do specific packaging types address diverse biopharma cold chain requirements?

The market is diversified by packaging types like Insulated Containers and Temperature-Controlled Shippers, which are crucial for maintaining specific temperature ranges for various biopharmaceutical products. Cryogenic Packaging, though a smaller segment, is vital for extremely sensitive materials such as cellular therapies, requiring ultra-low temperatures. Phase Change Material Packaging further enhances these solutions by offering precise temperature control for extended durations, adapting to varying product needs and environmental conditions.

Which end users are primarily driving the demand for biopharma cold chain packaging solutions?

Pharmaceutical Companies and Biotechnology Companies are the primary drivers of demand, as they are responsible for developing, manufacturing, and distributing the vast majority of temperature-sensitive biopharmaceutical products. Logistics Providers play a crucial supporting role by offering specialized cold chain transportation and storage services, while Healthcare Institutions also contribute to demand through their need for safe and compliant handling of critical medications and samples for patient treatment and research.

What Regulatory and Policy Factors Shape the Global Biopharma Cold Chain Packaging Market

Global biopharma cold chain packaging is heavily regulated. Good Distribution Practices GDP from bodies like the FDA and EMA mandate precise temperature control and validated packaging systems ensuring product integrity. Regulations demand rigorous qualification protocols confirming packaging performance across diverse environmental conditions. Traceability requirements, exemplified by DSCSA and FMD, increasingly influence packaging design for serialization. Furthermore, evolving environmental policies promote sustainable materials and waste reduction strategies, driving innovation towards eco friendly solutions. Compliance with these complex global and regional mandates is paramount, necessitating continuous adaptation and investment in advanced, compliant packaging technologies for sensitive biopharmaceutical products.

What New Technologies are Shaping Global Biopharma Cold Chain Packaging Market?

The biopharma cold chain packaging market embraces significant innovations. Advanced phase change materials ensure precise temperature stability for sensitive biologics and cell gene therapies. Smart packaging, integrating IoT sensors, provides real time monitoring of temperature, humidity, and location, drastically improving product integrity and compliance across global distribution networks. Sustainable solutions, including recyclable and biodegradable materials, are gaining traction, addressing growing environmental concerns. Automated packaging processes enhance efficiency and minimize human error. Emerging digital platforms offer predictive analytics, optimizing logistics and inventory management. These technological advancements ensure safer, more efficient, and environmentally responsible global pharmaceutical delivery.

Global Biopharma Cold Chain Packaging Market Regional Analysis

Global Biopharma Cold Chain Packaging Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
38.2%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

North America dominates the global biopharma cold chain packaging market with a significant 38.2% share. This leadership is driven by a robust pharmaceutical and biotechnology industry, extensive R&D activities, and a high volume of clinical trials. The presence of major pharmaceutical companies, advanced logistics infrastructure, and stringent regulatory requirements for temperature-sensitive products further fuel market growth. The region's focus on innovative packaging solutions, including smart packaging and sustainable options, also contributes to its strong market position. Continued investment in biopharmaceutical research and development, coupled with an increasing demand for specialized cold chain logistics, ensures North America's sustained market dominance.

Europe's biopharma cold chain packaging market is robust, driven by its advanced pharmaceutical manufacturing and distribution networks. Germany, France, and the UK are key players, investing in sophisticated packaging solutions for temperature-sensitive biologics and vaccines. Strict EU regulations on pharmaceutical transport necessitate high-performance, compliant packaging. The region exhibits strong demand for sustainable and reusable packaging options, along with advanced temperature monitoring technologies. Growth is further fueled by the expanding European biopharmaceutical R&D landscape and the increasing prevalence of personalized medicines requiring stringent cold chain management. Eastern Europe is emerging as a growth pocket due to expanding manufacturing capabilities.

Asia Pacific spearheads the global biopharma cold chain packaging market with an impressive 11.2% CAGR, positioning itself as the fastest-growing region. This surge is fueled by expanding biopharmaceutical manufacturing hubs in countries like China, India, and South Korea, coupled with increasing investments in advanced cold chain infrastructure. The rising demand for biologics, vaccines, and cell & gene therapies, particularly for chronic diseases and infectious disease management, drives the need for sophisticated temperature-controlled packaging solutions. Government initiatives supporting pharmaceutical R&D and manufacturing also contribute significantly to the region's rapid market expansion and innovation in packaging technologies.

Latin America presents a dynamic cold chain packaging market driven by growing pharmaceutical manufacturing and increased access to complex biologics. Brazil leads with significant domestic production and clinical trial activity, while Mexico’s proximity to the US and strong medical device sector contribute significantly. Argentina and Colombia are emerging, boosted by government health programs and a rising middle class demanding advanced medicines. Challenges include varied infrastructure, regulatory complexities, and the need for cost-effective, sustainable solutions adaptable to diverse climates and last-mile delivery. Demand for insulated shippers, temperature-controlled containers, and real-time monitoring solutions is escalating across the-region.

Middle East & Africa’s biopharma cold chain packaging market is experiencing robust growth driven by increasing healthcare infrastructure and rising demand for specialized medicines. The region, particularly Gulf countries and South Africa, is investing heavily in advanced cold chain logistics to accommodate complex biologics and vaccines. Challenges include diverse climates and infrastructure disparities, pushing demand for robust, passive packaging solutions. Local manufacturing expansion and a focus on sustainability are further shaping market dynamics. The need for temperature-controlled solutions across vast, varied geographies makesMEA a crucial growth region, attracting innovation in insulated shippers and smart packaging.

Top Countries Overview

The US dominates global biopharma cold chain packaging, driven by its expansive pharmaceutical industry and robust R&D. Demand for advanced insulated solutions is rising due to increased complex biologics and stringent regulatory requirements ensuring product integrity and safety throughout the supply chain.

China dominates global biopharma cold chain packaging, driven by its vast manufacturing base, growing demand for temperature-sensitive drugs, and strong government support. Domestic companies are rapidly innovating to meet increasing needs for precise temperature control and efficient, sustainable solutions, solidifying its pivotal role in the global pharmaceutical supply chain.

India's biopharma cold chain packaging market is booming, driven by vaccine production and expanding biotech. It plays a crucial role in global drug delivery, with innovations in temperature control and sustainable materials. The country is a key supplier and consumer, ensuring product integrity from manufacturing to patient, supporting global health initiatives.

Impact of Geopolitical and Macroeconomic Factors

Geopolitical shifts, particularly trade wars and regional conflicts, disrupt global supply chains for specialized pharma packaging materials and temperature controlled logistics. Export controls on advanced materials and manufacturing technologies by key nations also impact market access and innovation. Geopolitical tensions can lead to reshoring or nearshoring of biopharma production, subsequently shifting demand for cold chain packaging regionally.

Macroeconomic factors like inflation significantly impact raw material costs for insulation and phase change materials. Currency fluctuations affect import costs and profitability for international suppliers. Economic growth in emerging markets boosts demand for advanced biopharmaceuticals and their associated cold chain packaging, especially for new gene and cell therapies requiring ultracold conditions. Regulatory changes regarding packaging safety and environmental sustainability further shape market trends.

Recent Developments

  • March 2025

    Pelican BioThermal acquired a key player in passive temperature-controlled packaging solutions, strengthening its market dominance. This acquisition expands Pelican BioThermal's product portfolio and global distribution network, particularly in emerging biopharma markets.

  • July 2024

    Cold Chain Technologies partnered with a leading logistics provider to develop an integrated digital tracking system for temperature-sensitive shipments. This collaboration aims to enhance real-time visibility and ensure end-to-end integrity of biopharma cold chain logistics.

  • September 2024

    MilliporeSigma launched a new line of sustainable, reusable cold chain packaging solutions for gene therapy applications. These innovative containers utilize advanced insulation materials and aim to reduce environmental impact while maintaining stringent temperature control.

  • February 2025

    AptarGroup announced a strategic initiative to invest heavily in smart packaging technologies for the biopharma cold chain, focusing on integrated sensors and data logging capabilities. This move aims to provide pharmaceutical companies with enhanced data and predictive analytics for shipment monitoring.

  • November 2024

    Sofrigam introduced a new high-performance, compact packaging solution specifically designed for last-mile delivery of individualized cell and gene therapies. This product addresses the unique challenges of maintaining ultra-cold temperatures for personalized medicines in diverse environments.

Key Players Analysis

Leading the Global Biopharma Cold Chain Packaging Market are key players like American Biopharma and Pelican BioThermal, specializing in high performance thermal shippers. Sofrigam and Cold Chain Technologies provide advanced insulated containers and phase change materials, crucial for maintaining temperature integrity. MilliporeSigma and VWR offer comprehensive laboratory and cold chain solutions, integrating packaging with broader scientific needs. Temptime Corporation focuses on innovative temperature indicators, enhancing product safety and compliance. Strategic initiatives include expanding global distribution networks, investing in sustainable packaging solutions like reusable containers, and developing smart packaging with real time monitoring capabilities. Market growth is driven by the increasing demand for temperature sensitive biologics, stricter regulatory requirements, and the globalization of pharmaceutical supply chains, all necessitating robust and reliable cold chain packaging.

List of Key Companies:

  1. American Biopharma
  2. Sofrigam
  3. Cold Chain Technologies
  4. MilliporeSigma
  5. Temptime Corporation
  6. VWR
  7. Pelican BioThermal
  8. Weiss Umweltstechnik
  9. AptarGroup
  10. Brambles Limited
  11. Gerresheimer
  12. DHL Supply Chain
  13. CSafe Global
  14. BD
  15. Sonoco Products Company
  16. Thermo Fisher Scientific

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 28.5 Billion
Forecast Value (2035)USD 74.3 Billion
CAGR (2026-2035)8.7%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Packaging Type:
    • •Insulated Containers
    • •Temperature-Controlled Shippers
    • •Cryogenic Packaging
    • •Phase Change Material Packaging
  • By Application:
    • •Vaccines
    • •Biologics
    • •Pharmaceuticals
    • •Cellular Therapies
  • By End User:
    • •Pharmaceutical Companies
    • •Biotechnology Companies
    • •Logistics Providers
    • •Healthcare Institutions
  • By Material Type:
    • •Plastic
    • •Glass
    • •Metal
    • •Composites
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Biopharma Cold Chain Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Packaging Type
5.1.1. Insulated Containers
5.1.2. Temperature-Controlled Shippers
5.1.3. Cryogenic Packaging
5.1.4. Phase Change Material Packaging
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.2.1. Vaccines
5.2.2. Biologics
5.2.3. Pharmaceuticals
5.2.4. Cellular Therapies
5.3. Market Analysis, Insights and Forecast, 2020-2035, By End User
5.3.1. Pharmaceutical Companies
5.3.2. Biotechnology Companies
5.3.3. Logistics Providers
5.3.4. Healthcare Institutions
5.4. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
5.4.1. Plastic
5.4.2. Glass
5.4.3. Metal
5.4.4. Composites
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Biopharma Cold Chain Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Packaging Type
6.1.1. Insulated Containers
6.1.2. Temperature-Controlled Shippers
6.1.3. Cryogenic Packaging
6.1.4. Phase Change Material Packaging
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.2.1. Vaccines
6.2.2. Biologics
6.2.3. Pharmaceuticals
6.2.4. Cellular Therapies
6.3. Market Analysis, Insights and Forecast, 2020-2035, By End User
6.3.1. Pharmaceutical Companies
6.3.2. Biotechnology Companies
6.3.3. Logistics Providers
6.3.4. Healthcare Institutions
6.4. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
6.4.1. Plastic
6.4.2. Glass
6.4.3. Metal
6.4.4. Composites
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Biopharma Cold Chain Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Packaging Type
7.1.1. Insulated Containers
7.1.2. Temperature-Controlled Shippers
7.1.3. Cryogenic Packaging
7.1.4. Phase Change Material Packaging
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.2.1. Vaccines
7.2.2. Biologics
7.2.3. Pharmaceuticals
7.2.4. Cellular Therapies
7.3. Market Analysis, Insights and Forecast, 2020-2035, By End User
7.3.1. Pharmaceutical Companies
7.3.2. Biotechnology Companies
7.3.3. Logistics Providers
7.3.4. Healthcare Institutions
7.4. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
7.4.1. Plastic
7.4.2. Glass
7.4.3. Metal
7.4.4. Composites
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Biopharma Cold Chain Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Packaging Type
8.1.1. Insulated Containers
8.1.2. Temperature-Controlled Shippers
8.1.3. Cryogenic Packaging
8.1.4. Phase Change Material Packaging
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.2.1. Vaccines
8.2.2. Biologics
8.2.3. Pharmaceuticals
8.2.4. Cellular Therapies
8.3. Market Analysis, Insights and Forecast, 2020-2035, By End User
8.3.1. Pharmaceutical Companies
8.3.2. Biotechnology Companies
8.3.3. Logistics Providers
8.3.4. Healthcare Institutions
8.4. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
8.4.1. Plastic
8.4.2. Glass
8.4.3. Metal
8.4.4. Composites
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Biopharma Cold Chain Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Packaging Type
9.1.1. Insulated Containers
9.1.2. Temperature-Controlled Shippers
9.1.3. Cryogenic Packaging
9.1.4. Phase Change Material Packaging
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.2.1. Vaccines
9.2.2. Biologics
9.2.3. Pharmaceuticals
9.2.4. Cellular Therapies
9.3. Market Analysis, Insights and Forecast, 2020-2035, By End User
9.3.1. Pharmaceutical Companies
9.3.2. Biotechnology Companies
9.3.3. Logistics Providers
9.3.4. Healthcare Institutions
9.4. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
9.4.1. Plastic
9.4.2. Glass
9.4.3. Metal
9.4.4. Composites
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Biopharma Cold Chain Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Packaging Type
10.1.1. Insulated Containers
10.1.2. Temperature-Controlled Shippers
10.1.3. Cryogenic Packaging
10.1.4. Phase Change Material Packaging
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.2.1. Vaccines
10.2.2. Biologics
10.2.3. Pharmaceuticals
10.2.4. Cellular Therapies
10.3. Market Analysis, Insights and Forecast, 2020-2035, By End User
10.3.1. Pharmaceutical Companies
10.3.2. Biotechnology Companies
10.3.3. Logistics Providers
10.3.4. Healthcare Institutions
10.4. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
10.4.1. Plastic
10.4.2. Glass
10.4.3. Metal
10.4.4. Composites
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. American Biopharma
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. Sofrigam
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. Cold Chain Technologies
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. MilliporeSigma
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. Temptime Corporation
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. VWR
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Pelican BioThermal
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. Weiss Umweltstechnik
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. AptarGroup
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. Brambles Limited
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Gerresheimer
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. DHL Supply Chain
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. CSafe Global
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. BD
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis
11.2.15. Sonoco Products Company
11.2.15.1. Business Overview
11.2.15.2. Products Offering
11.2.15.3. Financial Insights (Based on Availability)
11.2.15.4. Company Market Share Analysis
11.2.15.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.15.6. Strategy
11.2.15.7. SWOT Analysis
11.2.16. Thermo Fisher Scientific
11.2.16.1. Business Overview
11.2.16.2. Products Offering
11.2.16.3. Financial Insights (Based on Availability)
11.2.16.4. Company Market Share Analysis
11.2.16.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.16.6. Strategy
11.2.16.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035

Table 2: Global Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 3: Global Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 4: Global Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 5: Global Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035

Table 7: North America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 8: North America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 9: North America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 10: North America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035

Table 12: Europe Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 13: Europe Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 14: Europe Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 15: Europe Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035

Table 17: Asia Pacific Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 18: Asia Pacific Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 19: Asia Pacific Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 20: Asia Pacific Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035

Table 22: Latin America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 23: Latin America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 24: Latin America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 25: Latin America Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Packaging Type, 2020-2035

Table 27: Middle East & Africa Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 28: Middle East & Africa Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 29: Middle East & Africa Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 30: Middle East & Africa Biopharma Cold Chain Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Packaging Transport Market Research

Explore comprehensive market research reports covering all aspects of the Packaging Transport industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;